BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1495291)

  • 1. Comparison of two transfusion strategies after elective operations for myocardial revascularization.
    Johnson RG; Thurer RL; Kruskall MS; Sirois C; Gervino EV; Critchlow J; Weintraub RM
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):307-14. PubMed ID: 1495291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of fluid restriction policy in reducing the use of red blood cells in cardiac surgery.
    Vretzakis G; Kleitsaki A; Stamoulis K; Dragoumanis C; Tasoudis V; Kyriakaki K; Mikroulis D; Giannoukas A; Tsilimingas N
    Acta Anaesthesiol Belg; 2009; 60(4):221-8. PubMed ID: 20187484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting.
    Puskas JD; Williams WH; Duke PG; Staples JR; Glas KE; Marshall JJ; Leimbach M; Huber P; Garas S; Sammons BH; McCall SA; Petersen RJ; Bailey DE; Chu H; Mahoney EM; Weintraub WS; Guyton RA
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):797-808. PubMed ID: 12698142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparison of autologous transfusion procedures in hip surgery].
    Lorentz A; Osswald PM; Schilling M; Jani L
    Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate preoperative phlebotomy with autologous blood donation for aortic replacement.
    Paty PS; Shah DM; Chang BB; Kaufman JL; Feustel PJ; Leather RP
    Surg Gynecol Obstet; 1990 Oct; 171(4):326-30. PubMed ID: 2218838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of blood utilization during myocardial revascularization.
    Dietrich W; Barankay A; Dilthey G; Mitto HP; Richter JA
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):213-9. PubMed ID: 2783753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique.
    Rosengart TK; Helm RE; DeBois WJ; Garcia N; Krieger KH; Isom OW
    J Am Coll Surg; 1997 Jun; 184(6):618-29. PubMed ID: 9179119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autotransfusion with leap-frog technique in patients with coronary heart disease and planned aortocoronary venous bypass].
    Kiesewetter H; Jung F; Pindur G; Koscielny J; Jakobs K; Wenzel E
    Infusionsther Transfusionsmed; 1994 Apr; 21(2):96-103. PubMed ID: 7517239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure.
    Surgenor SD; DeFoe GR; Fillinger MP; Likosky DS; Groom RC; Clark C; Helm RE; Kramer RS; Leavitt BJ; Klemperer JD; Krumholz CF; Westbrook BM; Galatis DJ; Frumiento C; Ross CS; Olmstead EM; O'Connor GT
    Circulation; 2006 Jul; 114(1 Suppl):I43-8. PubMed ID: 16820613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding.
    Helm RE; Klemperer JD; Rosengart TK; Gold JP; Peterson P; DeBois W; Altorki NK; Lang S; Thomas S; Isom OW; Krieger KH
    Ann Thorac Surg; 1996 Nov; 62(5):1431-41. PubMed ID: 8893580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of acute autologous blood transfusion on coagulation dysfunction after cardiopulmonary bypass.
    Zisman E; Eden A; Shenderey A; Meyer G; Balagula M; Ammar R; Pizov R
    Eur J Anaesthesiol; 2009 Oct; 26(10):868-73. PubMed ID: 19528806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.
    Jarnagin WR; Gonen M; Maithel SK; Fong Y; D'Angelica MI; Dematteo RP; Grant F; Wuest D; Kundu K; Blumgart LH; Fischer M
    Ann Surg; 2008 Sep; 248(3):360-9. PubMed ID: 18791356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis.
    Ferraris VA; Gildengorin V
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):492-7. PubMed ID: 2796356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of blood conservation.
    Weisel RD; Charlesworth DC; Mickleborough LL; Fremes SE; Ivanov J; Mickle DA; Teasdale SJ; Glynn MF; Scully HE; Goldman BS
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):26-38. PubMed ID: 6376959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor predictive value of hematocrit and hemodynamic parameters for erythrocyte deficits after extensive elective vascular operations.
    Cordts PR; LaMorte WW; Fisher JB; DelGuercio C; Niehoff J; Pivacek LE; Dennis RC; Siebens H; Georgio A; Valeri CR
    Surg Gynecol Obstet; 1992 Sep; 175(3):243-8. PubMed ID: 1514159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study.
    Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.